Beyond teledermatology
What is Pathpoint eDerma?
Pathpoint eDerma is a powerful, cloud-based teledermatology platform built to adapt to the needs of your team and community. It enables you to coordinate dermatology services with ease, supporting care models that are responsive, efficient, and tailored to your population. Whether you’re working with limited resources or scaling a larger programme, eDerma is designed to meet your needs.
The Pathpoint eDerma Outcomes Report is out!
Explore the real-world benefits of eDerma-powered teledermatology from a project commissioned by the NHS Cancer Programme with support from SBRI Healthcare.
Proven success
100% clinician satisfaction
£45 average savings per patient diagnosis when all costs, including eDerma, are considered
18% reduction in unnecessary procedures, increasing cost savings up to £135
93.6% of patients diagnosed or given treatment decisions at time of assessment
85.8% reduction in face-to-face appointments
5 min average assessment time, increasing consultant capacity fourfold
28-day FDS attainment for most patients despite 88% increase in referrals
Patients diagnosed 14 days faster on average
Equal referral-to-diagnosis times for all patient groups
Integration with e-RS and EPR systems
Sign-on-screen consent and clinically-coded images for education and research
Patient co-designed questionnaires for improved accessibility and understanding
Automated outcome letters, GP notes, and diagnosis-specific leaflets
Streamlined dermatology pathways, including biopsy planning, MDT, and governance assessments
Procedure list planning & perioperative specialist pathways
Efficient remote triaging for inpatient and outpatient referrals
End-to-end pathway from referral to discharge
Hear what our clients are saying
Open Medical colleagues were well engaged in the project working groups to support mobilisation of the pathway within a tight timeframe, delivered training to clinical, operational and administrative teams, and were on-site to provide support during go-live. The impact has been significant, saving two weeks on the time to the first appointment and improving our performance against the Faster Diagnosis from 49.8% prior to implementation to sustained delivery of the standard since December 2023.
Rachel Pearson,
Head of Cancer Services Development at the Northern Care Alliance NHS Foundation Trust
Value for everyone
Digital Lead
Clinically safe
IG compliant
Cloud-based software with role-based access
Patients
Clinically safe
IG compliant
Cloud-based software with role-based access
Payers
Embedded patient information for shared decision making
Digital consent workflow
Clinical teams
Visibility of workload
Optimised legacy processes
Significant cost reductions
